MONTREAL, 01 October 2020 (GLOBE NEWSWIRE) – The Canadian Working Group on COVID-19 Immunity (CITF) announces its new study on the seroprevalence of SARS-CoV-2 aimed at the aging of Canadians, a maximum population at threat of serious consequences of COVID-19. This $4 million investment will be made through the Canadian Longitudinal Study on Aging (CSLS), a national platform for aging studies in Canada, led by McMaster University.
The C CVSA SEroprevalence exam will collect and analyze the blood patterns of more than 19,000 CVSL participants in 10 provinces. In addition to offering blood standards, LSCL exam participants will complete a questionnaire that will collect data on symptoms, threat factors, and fitness use. care, and the psychosocial and economic effects of COVID-19. Linking the effects on the presence of antibodies and other immune markers of blood pattern analysis with the effects of the SCVS questionnaire will provide a more complete picture of the prevalence of SARS-CoV-2 and have an effect on COVID-19 in older adults in Canada.
“Based on LSCL’s extensive knowledge collection and infrastructure, the two-component technique for examination will allow us to estimate the degrees of immunity among older Canadians and give us a greater understanding of some of the points that influence their experience with the disease,” says Dr. Parminder Raina, lead researcher of the study and professor at the Department of Health Research Methods. Fix evidence and take effect at McMaster University.
”In a nut words, blood sample research will show how widespread SARS-CoV-2 infection is among men and women over the age of 50, while the questionnaire will inform us about the lives of those other people since the beginning of the ”pandemic’, adds Dr. Raina “Together, this data will allow us to better perceive the transmission dynamics and threat points related to SARS-CoV-2 infection in older adults. “
The study, to be presented this fall, is led by lead researcher Dr. Parminder Raina of McMaster University (Hamilton) and co-principal researchers, Drs. Susan Kirkland (Dalhousie University, Halifax) and Christina Wolfson (McGill University, Montreal). and a national of researchers.
“Protecting others at the top of the threat of serious consequences, adding aging Canadians, is a wiser precedent in our continued control of COVID-19 in Canada,” says Dr. Theresa Tam, Director of Public Health of Canada. ” Other older people are at increased threat of illness due to their age and other underlying medical conditions. Improving our immunity in height-threatening populations will allow us to plan and focus our approaches to public aptitude.
ABOUT THE CANADIAN LONGITUDINAL STUDY ON AGING
The Canadian Longitudinal Study on Aging (CSLS) is one of the key policy projects of the Canadian Institutes of Health Research (CHR) and has been supported through the Institute of Aging. The basic objective of this initiative is to mobilize network experts to generate the clinical content of a longitudinal study platform that will enable interdisciplinary population studies and evidence-based decision-making that will lead to greater aptitude and quality of life for Canadians The COVID-19 LVAL team is an interdisciplinary organization of scholars with geriatric experience , epidemiology of infectious diseases, clinical chemistry, medicine, microbiology, immunology, statistics, genetics and social sciences.
The Government of Canada presented the COVID-19 immunity Working Group (CITF) in April 2020 to monitor the spread of the virus in the general population and populations of precedence in Canada. -CoV-2 in a variety of communities, age equipment, populations and occupational equipment throughout the country. To produce this information, the working group relies on experts from universities and hospitals across Canada, works largely with provincial and territorial public aptitude officers, and engages communities and stakeholders from the outset in spreading results. For more information, visit: www. covid19immunitytaskforce. ca
MEDIA CONTACTS
COVID-19 Immunity Working Group Caroline Phaneuf / Rebecca Burnsmedia@covid19immunitytaskforce. ca
Caroline Cell: 1-514-778-5092 Media Relations, Faculty of Health Sciences, McMaster Veronica University McGuirevmcguir@mcmaster. ca
Veronica Cell: 1-289-776-6952